Dr Kishan Rees, MbChb, MMedSci, eMBA, MD - Senior Life Sciences Executive & Digital Innovation Leader Multi award-winning pharmaceutical physician and digital strategist currently serving as Senior Director of Global Video & Digital Content Strategy at Bayer. With over 15 years combining clinical medicine, pharmaceutical leadership, and digital innovation, I drive patient-centric solutions across global life sciences organizations. Awards: Team, American Association of Kidney Patients (AAKP) Global award for excellence in Kidney Science & Communication 2025. Awarded to Bayer Global. Personal contribution was for digital strategy behind Heart & Kidney Care Alliance. Individual, Pharmaceutical Marketing Society Pioneer of 2025. Awarded for building GME:X by Bayer and D:CAM - The Digital Content Acceleration Method. Core Expertise: Medical Affairs Leadership | Digital Transformation | Global Strategy | Cross-Functional Team Management | Medical Communications | AI-Enabled Research | Stakeholder Engagement Academic Excellence: MD (PhD equivalent) in Medical Science from Hull York Medical School, focusing on COVID-19 public health communication using artificial intelligence as an analytical tool. Executive MBA (Merit) in Entrepreneurship & Innovation from Nottingham University Business School. MMedSci in Medical Education from Nottingham Medical School (Distinction). MbChB from University of Leicester, winning the Roche Pharmaceuticals prize. Leadership Track Record: Successfully led teams of 4-14 professionals across therapeutic areas including cardiovascular, dermatology, and immunology. Pioneered the D:CAM (Digital Content Acceleration Method), reducing time-to-market for compliant medical content while scaling from single deployments to 100+ content pieces. Developed GME:X (Global Medical Education Xchange), a world-class digital platform deployed across US, Japan, India, and UK markets. Strategic Innovation: Spearheaded 'Glo-cal' content strategies balancing global consistency with local market needs. Initiated mixed marketing model ROI pilots demonstrating measurable business impact. Created multiple social media brands enhancing corporate reputation and stakeholder engagement. Expertise in omnichannel solutions and digital transformation within regulatory frameworks. Thought Leadership: Regular contributor to Sky News (110M global reach) covering major health stories including COVID-19 pandemic coverage. Invited speaker at prestigious industry events including Reuters Barcelona and Pharmageddon. Mentor for NHS England Clinical Entrepreneur Programme and board member of Greater Lincolnshire Local Enterprise Partnership. Clinical Foundation: 10 years clinical practice across General Surgery, Trauma & Orthopaedics, and Emergency Medicine. This clinical background informs patient-centric approaches to pharmaceutical strategy and medical communications. Digital Innovation: As a researcher with dyslexia, I pioneered innovative methodologies incorporating AI tools like ChatGPT for qualitative research analysis, demonstrating adaptive leadership and technological integration in academic research. Global Impact: Proven ability to drive cross-cultural collaboration and knowledge transfer across markets including Nordic, European, Japanese, and US teams. Experience advising UK government during COVID-19 crisis and managing global pharmaceutical portfolios worth millions in revenue. My unique combination of clinical expertise, business acumen, digital innovation, and proven leadership positions me to drive strategic transformation in the evolving life sciences landscape, particularly in medical affairs, marketing, digital health, and global pharmaceutical strategy roles.